» Articles » PMID: 2884248

Detection of Thyroid-stimulating Antibodies in Thyroid Diseases, Employing Rat Thyroid Fragment Perifusion

Overview
Publisher Springer
Specialty Endocrinology
Date 1987 Apr 1
PMID 2884248
Authors
Affiliations
Soon will be listed here.
Abstract

The technique of perifusing rat thyroid fragments was used to investigate the presence of thyroid-stimulating antibodies (TSAb) in the sera of 48 patients. Response to IgG was measured by determining the mean rate of release of T4 (R) during a 30-min perifusion and the secretion peak (Imax) by means of samples taken every 5 min. Values found to be above the mean + 2 SD of the control values of R or Imax were considered to be positive. TSAb were found in all the 17 patients with untreated Graves' disease (GD) and in the 2 treated with antithyroid drugs, but not in the 3 who had undergone surgery or 131I treatment or in the 2 on corticosteroid treatment. TSAb were also found in 2 out of 3 patients with untreated nodular toxic goiter (UNTG) and in 6 out of 8 with diffuse nontoxic goiter (DNG) but at lower levels. In the untreated GD group, R and Imax correlated significantly with the corresponding IgG concentrations (from 90 to 800 micrograms/ml), suggesting TSAb activity which can be compared from one patient to another. TSAb activity did not correlate with thyroid function tests in any group. In all the groups it induced an early secretion peak followed by a decreasing response throughout the stimulation period, as was previously found with 65 mIU/ml TSH. The specificity of this technique was verified by five different control methods: the perifusion technique was checked by using KRBG buffer alone; sera were studied from a group of healthy controls.(ABSTRACT TRUNCATED AT 250 WORDS)

References
1.
Chiovato L, Hammond L, Hanafusa T, Pujol-Borrell R, Doniach D, Bottazzo G . Detection of thyroid growth immunoglobulins (TGI) by [3H]-thymidine incorporation in cultured rat thyroid follicles. Clin Endocrinol (Oxf). 1983; 19(5):581-90. DOI: 10.1111/j.1365-2265.1983.tb00034.x. View

2.
Brown R, Jackson I, POHL S, Reichlin S . Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?. Lancet. 1978; 1(8070):904-6. DOI: 10.1016/s0140-6736(78)90682-7. View

3.
Rapoport B, Takai N, Filetti S . Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue. J Clin Endocrinol Metab. 1982; 54(5):1059-62. DOI: 10.1210/jcem-54-5-1059. View

4.
Adams D, KENNEDY T . Evidence to suggest that LATS protector stimulates the human thyroid gland. J Clin Endocrinol Metab. 1971; 33(1):47-51. DOI: 10.1210/jcem-33-1-47. View

5.
Sugenoya A, Kidd A, Row V, Volpe R . Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. J Clin Endocrinol Metab. 1979; 48(3):398-402. DOI: 10.1210/jcem-48-3-398. View